52 results
Page 2 of 3
8-K
EX-10.1
zvi7z j15nongg
28 Apr 22
Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market
5:03pm
8-K
EX-10.1
63z5jr
8 Apr 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.2
c95tmdg2b7dv6q8
14 Mar 22
Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market
6:42pm
8-K
EX-10.1
cagn xi6hlz8bn
14 Mar 22
Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market
6:42pm
8-K
EX-10.3
qe3cb115kzhmgpzw7
14 Mar 22
Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market
6:42pm
8-K
EX-10.5
lyz3nfpt3 02fdb6
14 Mar 22
Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market
6:42pm
8-K
EX-10.4
l219g6kaj4q8
14 Mar 22
Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market
6:42pm
8-K
EX-10.1
5nv32m0
25 Feb 22
Sunshine Biopharma Expands Anti-coronavirus Drug Development Program by Signing a Collaboration Agreement with the University of Arizona
8:00am
8-K
EX-10.1
s78khi55qe6yc7n0
17 Feb 22
Sunshine Biopharma, Inc. Announces Pricing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market
10:25am
8-K
EX-10.15
wm7d6o c3
15 Sep 20
Sunshine Biopharma Secures $2,000,000 + Financing
8:36am
8-K
EX-10.14
fv7i3
19 Jul 19
Termination of a Material Definitive Agreement
4:04pm
8-K
EX-10.1
mjx29wa7q1r wby
14 Sep 18
Sunshine Biopharma Announces $10 Million Equity Financing
12:00am
8-K
EX-10.2
3mk0f ze0xtkvmep5vpb
14 Sep 18
Sunshine Biopharma Announces $10 Million Equity Financing
12:00am
8-K
EX-10.13
j24ay34y
4 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.10
i2zk2mk1
14 Mar 16
SUNSHINE BIOPHARMA ELIMINATES THE DEBT OBLIGATIONS ASSOCIATED WITH THE RECENTLY ACQUIRED PATENTS FOR IT’S Adva-27a ANTICANCER COMPOUND
12:00am